Tune Therapeutics, Inc. — Form D

Tune Therapeutics, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2025-01-24. The offering totals $208.0M, of which $182.4M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2025-01-24
• Form: D
• Accession: 0002053139-25-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $208.0M
• Amount sold: $182.4M
• Remaining: $25.6M
• Investors: 39
• Date of first sale: 2023-03-09
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-536110

Issuer

• Name: Tune Therapeutics, Inc.
• CIK: 0002053139
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2020
• Address: 1930 Boren Avenue, Floor 5, SEATTLE, WA, 98101
• Phone: (855) 755-8863

Officers, directors & promoters (10)

More

• CIK 2053139 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search